RS

Rajat Sharma

Active Director Director DIN 11082060
DIN 11082060 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Rajat Sharma

Data last updated:

Rajat Sharma is a Director at Adjener Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Adjener Pharmaceuticals Private Limited reported revenue of ₹84.8 Lakh (FY 2024).

DIN 11082060
Primary Designation Director
Industry Pharma
First Appointment 30 Apr 2025
Oldest Company Age 5 yrs
Largest company Adjener Pharmaceuticals Private Limited · ₹84.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Apr 20252021₹84.8 Lakh (FY 2024)Active

Board colleagues of Rajat Sharma

Directorship timeline

Open interactive timeline →
Adjener Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajat Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajat Sharma

Rajat Sharma currently holds 1 directorship: Adjener Pharmaceuticals Private Limited (Director, since 30 Apr 2025, revenue ₹84.8 Lakh (FY 2024)).

Rajat Sharma was first appointed on 30 Apr 2025 as Director at Adjener Pharmaceuticals Private Limited.

The current boards of Rajat Sharma's companies include Karan Singh (Adjener Pharmaceuticals Private Limited), Kumar Mrigendra (Adjener Pharmaceuticals Private Limited), Preeti Kumari (Adjener Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available